Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 2/2007

01-02-2007

Incidence and Treatment of Tracheal Cancer: A Nationwide Study in The Netherlands

Authors: Jimmie Honings, MS, Jos A. A. M. van Dijck, PhD, Ad F. T. M. Verhagen, MD, PhD, Henricus F. M. van der Heijden, MD, PhD, Henri A. M. Marres, MD, PhD

Published in: Annals of Surgical Oncology | Issue 2/2007

Login to get access

Abstract

Background

The aim of this study was to assess the incidence, characteristics, treatment, and survival of patients with tracheal malignancies in the Netherlands.

Methods

All cases of tracheal cancer entered into the database of the Netherlands Cancer Registry in the period 1989–2002 were selected. Data on histological type, age at time of diagnosis, treatment, and survival were analyzed retrospectively.

Results

The annual incidence was 0.142 per 100,000 inhabitants (308 cases, of which 15 were found incidentally at autopsy). Of these, 72% were men. In 52.9%, the histological type was squamous cell carcinoma and in only 7.1% adenoid cystic carcinoma (ACC). Mean age at time of diagnosis was 64.3 years. Of the 293 patients diagnosed while alive, 34 patients underwent surgical resection (11.6%), 156 patients received radiotherapy (53.2%), and 103 patients neither (35.4%). Median survival of all 293 patients was 10 months (mean 28 months) with 1-year, 5-year, and 10-year survival rates of 43%, 15%, and 6%, respectively. The prognosis of patients with ACC was significantly better. The 5-year survival rate in patients who underwent surgical resection was 51%, and the 10-year survival rate in these patients was 33%.

Conclusion

The prognosis of patients with a tracheal malignancy is usually poor. Surgical treatment, however, can lead to good survival rates; still, this is currently only used in selected patients, even though it would seem to be possible in more cases in view of the technical advances in the field of tracheal surgery. Centralizing the care and treatment of tracheal cancers and implementing a more assertive attitude towards this disease could make surgery accessible to a larger number of patients. Data from the literature show that this would lead to better survival in patients with a tracheal malignancy.
Literature
1.
Manninen MP, Antila PJ, Pukander JS, Karma PH. Occurrence of tracheal carcinoma in Finland. Acta Otolaryngol 1991; 111:1162–9PubMed
2.
3.
Young JL, Percy CL, Asire AJ. Incidence and Mortality, Data, 1973–1977. In: U.S. Department of Health and Human Services. Surveillance, Epidemiology and End Results. Bethesda, Maryland: National Cancer Institute, 1981:87–91
4.
Heffner DK. (1985) Diseases of the trachea. In: Barnes L ed. Surgical Pathology of the Head and Neck, vol 1. New York: Marcel Dekker Inc, pp 487–531.
5.
Licht PB, Friis S, Pettersson G. Tracheal cancer in Denmark: a nationwide study. Eur J Cardiothorac Surg 2001; 19:339–45PubMedCrossRef
6.
Manninen MP, Pukander JS, Flander MK, Laippala PJ, Huhtala HS, Karma PH. Treatment of primary tracheal carcinoma in Finland in 1967–1985. Acta Oncol 1993; 32:277–82PubMedCrossRef
7.
8.
Mornex F, Coquard R, Danhier S, Maingon P, El Husseini G, Van Houtte P. Role of radiation therapy in the treatment of primary tracheal carcinoma. Int J Radiat Oncol Biol Phys 1998; 41:299–305PubMed
9.
Gaissert HA, Grillo HC, Shadmehr MB, Wright CD, Gokhale M, Wain JC, et al. Long-term survival after resection of primary adenoid cystic and squamous cell carcinoma of the trachea and carina. Ann Thorac Surg 2004; 78:1889–97PubMedCrossRef
10.
Grillo HC, Mathisen DJ. Primary tracheal tumors: treatment and results. Ann Thorac Surg 1990; 49:69–77PubMedCrossRef
11.
Regnard JF, Fourquier P, Levasseur P. Results and prognostic factors in resections of primary tracheal tumors: a multicenter retrospective study. The French Society of Cardiovascular Surgery. J Thorac Cardiovasc Surg 1996;111:808–13PubMedCrossRef
12.
13.
Li W, Ellerbroek NA, Libshitz HI. Primary malignant tumors of the trachea. A radiologic and clinical study. Cancer 1990; 66:894–9PubMedCrossRef
14.
Siesling S, van Dijck JA, Visser O, Coebergh JW. Trends in incidence of and mortality from cancer in The Netherlands in the period 1989–1998. Eur J Cancer 2003; 39:2521–30PubMedCrossRef
15.
Van Venrooij NA, Lenders JJ, Lammens MM, Van Krieken JH. Autopsy is a useful quality instrument because of unexpected clinically relevant findings and the answering of clinical questions; a retrospective study. Ned Tijdschr Geneeskd 2003; 147:1318–22PubMed
16.
Yang KY, Chen YM, Huang MH, Perng RP. Revisit of primary malignant neoplasms of the trachea: clinical characteristics and survival analysis. Jpn J Clin Oncol 1997; 27:305–9PubMedCrossRef
17.
18.
Schneider P, Schirren J, Muley T, Vogt-Moykopf I. Primary tracheal tumors: experience with 14 resected patients. Eur J Cardiothorac Surg 2001; 20:12–8PubMedCrossRef
19.
Hazama K, Miyoshi S, Akashi A, Yasumitsu T, Maeda H, Nakamura K, et al. Clinicopathological investigation of 20 cases of primary tracheal cancer. Eur J Cardiothorac Surg 2003; 23:1–5PubMedCrossRef
20.
Howard DJ, Haribhakti VV. Primary tumours of the trachea: analysis of clinical features and treatment results. J Laryngol Otol 1994; 108:230–2PubMedCrossRef
21.
Bhattacharyya N. Contemporary staging and prognosis for primary tracheal malignancies: a population-based analysis. Otolaryngol Head Neck Surg 2004; 131:639–42PubMedCrossRef
22.
Maziak DE, Todd TRJ, Keshavjee SH, Winton TL, Van Nostrand P, Pearson FG. Adenoid cystic carcinoma of the airway: thirty-two-year experience. J Thorac Cardiovasc Surg 1996; 112:1522–31PubMedCrossRef
23.
McCafferty GJ, Parker LS, Suggit SC. Primary malignant disease of the trachea. J Laryngol Otol 1964; 78:441–79PubMedCrossRef
24.
Albers E, Lawrie T, Harrell JH, Yi ES. Tracheobronchial adenoid cystic carcinoma: a clinicopathologic study of 14 cases. Chest 2004; 125:1160–5PubMedCrossRef
25.
Leon X, Quer M, Diez S, Orus C, Lopez-Pousa A, Burgues J. Second neoplasm in patients with head and neck cancer. Head Neck 1999; 21:204–10PubMedCrossRef
26.
Morita M, Araki K, Saeki H, Sakaguchi Y, Baba H, Sugimachi K, et al. Risk factors for multicentric occurrence of carcinoma in the upper aerodigestive tract-analysis with a serial histologic evaluation of the whole resected-esophagus including carcinoma. J Surg Oncol 2003; 83:216–21PubMedCrossRef
27.
Webb BD, Walsh GL, Roberts DB, Sturgis EM. Primary tracheal malignant neoplasms: the University of Texas MD Anderson Cancer Center experience. J Am Coll Surg 2006; 202:237–46PubMedCrossRef
28.
Allen MS. Malignant tracheal tumors. Mayo Clin Proc 1993; 68:680–4PubMed
29.
Wood DE. Management of malignant tracheobronchial obstruction. Surg Clin North Am 2002; 82:621–42PubMedCrossRef
30.
Chow DC, Komaki R, Libshitz HI, Mountain CF, Ellerbroek N. Treatment of primary neoplasms of the trachea. The role of radiation therapy. Cancer 1993; 71:2946–52PubMedCrossRef
31.
Grillo HC, Mathisen DJ, Wain JC. Management of tumors of the trachea. Oncology (Huntingt) 1992; 6:61–7
32.
Makarewicz R, Mross M. Radiation therapy alone in the treatment of tumours of the trachea. Lung Cancer 1998; 20:169–74PubMedCrossRef
33.
34.
Videtic GM, Campbell C, Vincent MD. Primary chemoradiation as definitive treatment for unresectable cancer of the trachea. Can Respir J 2003; 10:143–4PubMed
Metadata
Title
Incidence and Treatment of Tracheal Cancer: A Nationwide Study in The Netherlands
Authors
Jimmie Honings, MS
Jos A. A. M. van Dijck, PhD
Ad F. T. M. Verhagen, MD, PhD
Henricus F. M. van der Heijden, MD, PhD
Henri A. M. Marres, MD, PhD
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 2/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9229-z

Other articles of this Issue 2/2007

Annals of Surgical Oncology 2/2007 Go to the issue

OriginalPaper

Sentinel Node Biopsy and Concomitant Probe-Guided Tumor Excision of Nonpalpable Breast Cancer

OriginalPaper

Incidence Pattern and Survival for Gallbladder Cancer Over Three Decades—An Analysis of 10301 Patients

OriginalPaper

Lack of Evidence for Increased Operative Morbidity After Hepatectomy with Perioperative Use of Bevacizumab: A Matched Case-Control Study

OriginalPaper

Reduced Incidence of Nodal Micrometastasis after Major Response to Neoadjuvant Chemoradiation in Locally Advanced Esophageal Cancer

OriginalPaper

Comparison of Two Kinds of Intraperitoneal Chemotherapy Following Complete Cytoreductive Surgery of Colorectal Peritoneal Carcinomatosis

OriginalPaper

Value of the Sentinel Lymph Node Procedure in Patients With Large Size Breast Cancer